India Risks Becoming “Unhealthier Before It Becomes Richer,” CEA V Anantha Nageswaran Warns

IMT News Desk
IMT News Desk
· 1 min read
V Anantha Nageswaran warns India risks becoming unhealthier before richer due to rising obesity, sedentary lifestyles threatening productivity

Chief Economic Advisor V Anantha Nageswaran said India’s bigger worry isn’t ageing before it gets rich, but becoming unhealthier before it gets rich, pointing to rising obesity and sedentary lifestyles that threaten the country’s productivity dividend.

Responding to the question of whether India will age before it becomes rich due to falling birth rates and a shrinking youth bulge, Nageswaran said the working-age population will keep rising for some time, giving India a window.

“More than worrying about whether we are becoming older before we become richer, I would say whether we are becoming unhealthier before we become richer,” he said in an exclusive conversation.

He cited the NFHS (National Family Health Survey), which shows improvements in infant mortality, institutional births and maternal health, but “obesity across income levels, across rural or urban and across gender, it has worsened”.

Nageswaran attributed this to lifestyle, sedentary habits, lack of physical activity, poor urban design, and late evening eating.

The warning highlights that India faces a health challenge before achieving wealth, which could impact productivity and economic growth if not addressed through policy interventions and lifestyle changes.

Read Next

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk
India-UK FTA Opens Medical Device Trade, but Industry Wants Stronger Safeguards on Third-Country Rerouting
News
July 16, 2026

India-UK FTA Opens Medical Device Trade, but Industry Wants Stronger Safeguards on Third-Country Rerouting

The India-UK Comprehensive Economic and Trade Agreement has created a more favourable framework for medical device trade by paving the way for regulatory recognition and improved market access. Still, industry players are urging stronger safeguards to prevent third-country rerouting. The concern is that products from non-FTA countries, especially China, could be routed through the UK […]
Article by: IMT News Desk
Manipal Hospital, Millers Road Launches Sports Injury Care Centre for Specialised Knee and Shoulder Care
News
July 15, 2026

Manipal Hospital, Millers Road Launches Sports Injury Care Centre for Specialised Knee and Shoulder Care

 As participation in sports and fitness activities continues to rise across India, sports-related injuries are becoming increasingly common among both professional athletes and recreational fitness enthusiasts. Addressing this growing healthcare need, Manipal Hospital Millers Road has launched its dedicated Sports Injury Care Centre, offering specialised diagnosis and treatment for knee and shoulder injuries through advanced […]
Article by: IMT News Desk